Hypoxic preconditioning increases triiodothyronine (T3) level in the developing rat brain

Area of Science:

• Neuroscience
• Developmental Biology
• Endocrinology

Background:

• Neonatal hypoxic-ischemic encephalopathy (HIE) is a leading cause of infant brain injury and mortality.
• Hypoxic preconditioning (HPC) shows neuroprotective effects against HIE in animal models, but the underlying mechanisms in immature brains are unclear.
• Thyroid hormones (THs) are crucial for normal brain development.

Purpose of the Study:

• To investigate the role of thyroid hormones (THs), specifically triiodothyronine (T3), in the neuroprotective mechanisms of HPC in neonatal rats.
• To explore the involvement of THs, TH receptors (TRs), and deiodinases (D2, D3) in HPC-mediated neuroprotection.

Main Methods:

• Established a hypoxic preconditioning (HPC) model in neonatal rats (postnatal day 6).
• Assessed levels of THs, TRs, D2, D3 mRNA, glutamate transporter 1 (GLT1), and myelin basic protein (MBP) after HPC.
• Evaluated neuroprotection against HIE using immunohistochemical staining for MAP2 and MBP post-HPC.

Main Results:

• HPC treatment provided significant neuroprotection against HIE in neonatal rats.
• Local T3 levels increased post-HPC, likely due to upregulated D2 expression.
• Expression of MBP and GLT1, downstream targets of T3, was significantly elevated after HPC.

Conclusions:

• Thyroid hormones, particularly T3, are involved in the neuroprotective effects of hypoxic preconditioning during brain development.
• Upregulation of D2 and downstream targets like MBP and GLT1 contribute to HPC-mediated neuroprotection.
• This study highlights a potential therapeutic pathway involving THs for neonatal HIE.